Star Imaging and Path Lab Limited (BOM:544482)
India · Delayed Price · Currency is INR 72.50
+2.51 (3.59%)
At close: Jun 1, 2026
Star Imaging and Path Lab Revenue
In the fiscal year ending March 31, 2026, Star Imaging and Path Lab had annual revenue of 895.23M INR with 7.21% growth. Star Imaging and Path Lab had revenue of 451.91M in the half year ending September 30, 2025.
Revenue
895.23M
Revenue Growth
+7.21%
P/S Ratio
1.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 895.23M | 60.23M | 7.21% |
| Mar 31, 2025 | 835.00M | 47.16M | 5.99% |
| Mar 31, 2024 | 787.84M | 202.52M | 34.60% |
| Mar 31, 2023 | 585.32M | -105.53M | -15.28% |
| Mar 31, 2022 | 690.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.29B |
| One Global Service Provider | 4.99B |
| Chandan Healthcare | 2.81B |
| Modern Diagnostic & Research Centre | 814.48M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 249.82M |
| Clinitech Laboratory | 96.79M |
| Dr Lalchandani Labs | 43.80M |